588 related articles for article (PubMed ID: 25168939)
21. New oral anticoagulant agents - general features and outcomes in subsets of patients.
Schulman S
Thromb Haemost; 2014 Apr; 111(4):575-82. PubMed ID: 24452881
[TBL] [Abstract][Full Text] [Related]
22. [New clinical perspectives in the management of oral direct anticoagulant agents].
Marco P; Zamorano JL; Chana F; Llau JV
Med Clin (Barc); 2014 Feb; 142(4):171-8. PubMed ID: 23866969
[No Abstract] [Full Text] [Related]
23. Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series.
Beyer-Westendorf J; Michalski F; Tittl L; Hauswald-Dörschel S; Marten S
Lancet Haematol; 2016 Oct; 3(10):e480-e488. PubMed ID: 27692306
[TBL] [Abstract][Full Text] [Related]
24. Laboratory measurement of the direct oral anticoagulants.
Dale BJ; Chan NC; Eikelboom JW
Br J Haematol; 2016 Feb; 172(3):315-36. PubMed ID: 26492202
[TBL] [Abstract][Full Text] [Related]
25. Novel oral anticoagulants: a review of the literature and considerations in special clinical situations.
Akwaa F; Spyropoulos AC
Hosp Pract (1995); 2013 Feb; 41(1):8-18. PubMed ID: 23466963
[TBL] [Abstract][Full Text] [Related]
26. Management of hemorrhage with the target-specific oral anticoagulants.
Pluym M; Howell G
Hosp Pract (1995); 2014 Aug; 42(3):75-83. PubMed ID: 25255409
[TBL] [Abstract][Full Text] [Related]
27. Direct oral anticoagulants in the prevention of venous thromboembolism: evidence from major clinical trials.
Prandoni P; Temraz S; Taher A
Semin Hematol; 2014 Apr; 51(2):121-30. PubMed ID: 24861796
[TBL] [Abstract][Full Text] [Related]
28. Direct oral anticoagulants (DOACs).
Vazquez S; Rondina MT
Vasc Med; 2015 Dec; 20(6):575-7. PubMed ID: 26285587
[TBL] [Abstract][Full Text] [Related]
29. Acute management of bleeding in patients on novel oral anticoagulants.
Siegal DM; Crowther MA
Eur Heart J; 2013 Feb; 34(7):489-498b. PubMed ID: 23220847
[TBL] [Abstract][Full Text] [Related]
30. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.
Fawole A; Daw HA; Crowther MA
Cleve Clin J Med; 2013 Jul; 80(7):443-51. PubMed ID: 23821689
[TBL] [Abstract][Full Text] [Related]
31. Laboratory monitoring of the non-vitamin K oral anticoagulants.
Blann AD; Lip GY
J Am Coll Cardiol; 2014 Sep; 64(11):1140-2. PubMed ID: 25212649
[No Abstract] [Full Text] [Related]
32. Are new oral anticoagulant dosing recommendations optimal for all patients?
Powell JR
JAMA; 2015 Mar; 313(10):1013-4. PubMed ID: 25756434
[No Abstract] [Full Text] [Related]
33. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
Lane DA; Wood K
Circulation; 2015 Apr; 131(16):e412-5. PubMed ID: 25901074
[No Abstract] [Full Text] [Related]
34. Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.
Spyropoulos AC; Douketis JD; Gerotziafas G; Kaatz S; Ortel TL; Schulman S;
J Thromb Haemost; 2012 Apr; 10(4):692-4. PubMed ID: 22934291
[No Abstract] [Full Text] [Related]
35. Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug-Drug Interactions with Potential Perpetrator Drugs.
Mikus G; Foerster KI; Schaumaeker M; Lehmann ML; Burhenne J; Haefeli WE
Clin Pharmacokinet; 2019 Sep; 58(9):1155-1163. PubMed ID: 30828771
[TBL] [Abstract][Full Text] [Related]
36. Advantages and limitations of the new anticoagulants.
Schulman S
J Intern Med; 2014 Jan; 275(1):1-11. PubMed ID: 24112453
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?
Hellwig T; Gulseth M
Ann Pharmacother; 2013 Nov; 47(11):1478-87. PubMed ID: 24259602
[TBL] [Abstract][Full Text] [Related]
38. [New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].
Oberhofer E
MMW Fortschr Med; 2015 Jan; 157(1):24. PubMed ID: 25743289
[No Abstract] [Full Text] [Related]
39. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
40. Quick reference guide to apixaban.
Hurst KV; O'Callaghan JM; Handa A
Vasc Health Risk Manag; 2017; 13():263-267. PubMed ID: 28744136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]